[Federal Register Volume 81, Number 176 (Monday, September 12, 2016)]
[Notices]
[Pages 62747-62748]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-21785]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel R13 Conference Grant Review.
    Date: October 11, 2016.
    Time: 12:00 p.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 7W556, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Bratin K. Saha, Ph.D., Scientific Review 
Officer, Program Coordination and Referral Branch, Division of 
Extramural Activities, National Cancer Institute, 9609 Medical 
Center Drive, Room 7W556, Rockville, MD 20892-9750, 240-276-6411 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel Cancer Tissue Engineering Collaborative: Enabling Biomimetic 
Tissue-Engineered Technologies for Cancer Research (U01).
    Date: October 14, 2016.
    Time: 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda North Marriott Hotel & Conference Center, 5701 
Marinelli Road, Bethesda, MD 20852.
    Contact Person: Nadeem Khan, Ph.D., Scientific Review Officer, 
Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, 9609 Medical 
Center Drive, Room 7W260, Rockville, MD 20892-9750 240-276-5856, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel Cooperative Agreement to Develop Targeted Agents for use with 
Systemic Agents Plus Radiotherapy (U01).
    Date: October 21, 2016.
    Time: 10:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 7W030, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Thomas A. Winters, Ph.D., Scientific Review 
Officer, Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, 9609 Medical Center Drive, Room 7W412, 
Rockville, MD 20892-9750, 240-276-6386, [email protected].

    Name of Committee: National Cancer Institute Initial Review 
Group Subcommittee F--Institutional Training and Education.
    Date: October 24-25, 2016.
    Time: 7:30 p.m. to 3:45 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 
20814.
    Contact Person: Timothy C. Meeker, Ph.D., Scientific Review 
Officer, Resources and Training Review Branch, Division of 
Extramural Activities, National Cancer Institute, 9609 Medical 
Center Drive, Room 7W606, Rockville, MD 20892-9750, 240-276-6464, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, NCI Clinical and Translational, R21: SEP-7.
    Date: October 27, 2016.
    Time: 10:00 a.m. to 1:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Rockville, MD 20850 (Telephone Conference Call).
    Contact Person: Caron A. Lyman, Ph.D., Chief, Scientific Review 
Officer, Research Programs Review Branch, Division of Extramural 
Activities, National Cancer Institute, 9609 Medical Center Drive, 
Room 7W126, Rockville, MD 20892-9750, 240-276-6348, 
[email protected].


[[Page 62748]]


    Name of Committee: National Cancer Institute Special Emphasis 
Panel Multilevel Interventions in Cancer Care Delivery.
    Date: October 28, 2016.
    Time: 12:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 7W030, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Thomas A. Winters, Ph.D., Scientific Review 
Officer, Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, 9609 Medical Center Drive, Room 7W412, 
Rockville, MD 20892-9750, 240-276-6386, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Cancer Imaging, Radiotherapy, and Theranostics (R21).
    Date: November 2, 2016.
    Time: 11:00 a.m. to 5:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute, Shady Grove, 9609 Medical 
Center Drive, Room 7W554, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Christopher L. Hatch, Ph.D., Chief, Scientific 
Review Officer, Program Coordination and Referral Branch, Division 
of Extramural Activities, National Cancer Institute, 9609 Medical 
Center Drive, Room 7W554, Rockville, MD 20892-9750, 240-276-6454, 
[email protected].

    Name of Committee: National Cancer Institute Initial Review 
Group, Subcommittee J--Career Development.
    Date: November 3, 2016.
    Time: 8:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda North Marriott Hotel & Conference Center, 5701 
Marinelli Road, North Bethesda, MD 20852.
    Contact Person: Tushar Deb, Ph.D., Scientific Review Officer, 
Resources and Training Review Branch, Division of Extramural 
Activities, National Cancer Institute, 9609 Medical Center Drive, 
Room 7W624, Rockville, MD 20892-9750, 240-276-6132, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel NCI Provocative Questions--PQ9.
    Date: November 9, 2016.
    Time: 10:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 7W034, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Zhiqiang Zou, MD, Ph.D., Scientific Review 
Officer, Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, 9609 Medical Center Drive, Room 7W242, 
Rockville, MD 20892-9750, 240-276-6372, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, NCI Clinical and Translational R21: SEP-3.
    Date: November 15, 2016.
    Time: 9:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 7W624, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Tushar Deb, Ph.D., Scientific Review Officer, 
Resources and Training Review Branch, Division of Extramural 
Activities, National Cancer Institute, 9609 Medical Center Drive, 
Room 7W624, Rockville, MD 20892-9750, 240-276-6132, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel SBIR Bridge Awards.
    Date: December 7, 2016.
    Time: 11:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 4W032/034, Rockville, MD 20850 (Telephone 
Conference Call).
    Contact Person: Kenneth L. Bielat, Ph.D., Scientific Review 
Officer Research and Technology and Contract Review Branch, Division 
of Extramural Activities, National Cancer Institute, 9609 Medical 
Center Drive, Room 7W244, Rockville, MD 20892-9750, 240-276-6373, 
[email protected].

Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer 
Construction; 93.393, Cancer Cause and Prevention Research; 93.394, 
Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment 
Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers 
Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, 
National Institutes of Health, HHS)

    Dated: September 6, 2016.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-21785 Filed 9-9-16; 8:45 am]
 BILLING CODE 4140-01-P